Canada Pension Plan Investment Board Biocryst Pharmaceuticals Inc Transaction History
Canada Pension Plan Investment Board
- $96.3 Billion
- Q2 2024
A detailed history of Canada Pension Plan Investment Board transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 113,800 shares of BCRX stock, worth $905,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,800
Previous 113,800
-0.0%
Holding current value
$905,848
Previous $578,000
21.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$149 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$100 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$74.4 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$70.3 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.48B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...